Clinical Takeaway People with PTSD and co-occurring substance use disorders who use cannabis can still benefit meaningfully from trauma-focused treatments. Cannabis use does not appear to prevent evidence-based PTSD therapies from working,...
Drug Use May Double Stroke Risk: Study Analysing 100 Million People Warns | GRAVITAS
✦ New CED Clinical Relevance #65 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. NeurologySafetyResearchMental Health Why This Matters Clinicians should counsel patients that cannabis use is associated with...
Endocannabinoid System Research: Cannabis PTSD Meta-Analysis
Clinical Takeaway Trauma-focused treatments remain effective for PTSD even when patients are actively using cannabis, including those with co-occurring substance use disorders. Clinicians should not withhold or delay evidence-based PTSD care based...
`Cannabinoids in PTSD and Substance Use: Clinical Evidence`
Clinical Takeaway People with PTSD and co-occurring substance use disorders who also use cannabis can still benefit meaningfully from trauma-focused treatments. Clinicians should not withhold or delay evidence-based PTSD care based on...
`Endocannabinoid System & PTSD: Cannabis Meta-Analysis`
Clinical Takeaway People with PTSD and co-occurring substance use disorders who use cannabis can still benefit meaningfully from trauma-focused treatments. Cannabis use does not appear to prevent or significantly undermine the effectiveness...
`Cannabinoids for Children: Clinical Evidence Reviewed`
Clinical Takeaway Current evidence on cannabinoids in pediatric patients spans 276 studies across multiple designs, capturing both plant-derived and pharmaceutical formulations used to treat medical conditions in children under 18. The research...